We have previously demonstrated that chronic exposure of 3T3-L1 adipocytes to tumour
necrosis factor-alpha (TNF) resulted in a marked decrease (approximately 90%) in cellular GLUT4 (
insulin-responsive glucose transporter)
mRNA content as a result of a decreased transcription rate of the GLUT4 gene (approximately 75%) and a reduced half-life of its
mRNA (9 to 4.5 h). Investigation of the signalling mechanism responsible for this regulation demonstrated that in the 3T3-L1 adipocytes,
sphingomyelin levels decreased to 50% of control levels within 40 min of exposure to TNF, consistent with activation of a
sphingomyelinase. In the same manner as with TNF, treatment of the adipocytes with 1-3 microM
C6-ceramide, a membrane-permeable analogue of
ceramide, decreased GLUT4
mRNA content by approximately 60%. Subsequent investigations revealed that transcription of the GLUT4 gene was reduced by approximately 65% in response to
C6-ceramide, demonstrating that the decrease in
mRNA content is mediated by a reduction in the transcription of the genc. No effect on GLUT4 mRNA stability was observed after exposure of the adipocytes to
C6-ceramide. These observations are interesting in light of our previous data demonstrating that TNF affects both GLUT4 transcription and mRNA stability in the 3T3-L1 adipocytes. In conclusion, the effect of
ceramide on GLUT4 gene expression is at the level of transcription, suggesting that another pathway controls mRNA stability. These data establish that
ceramide-initiated signal transduction pathways exist within the adipocyte, and provide a potential mechanism for control of GLUT4 gene expression.